| Accession Number: | 0001562180-20-000321 |
| Date: | 2020-01-08 |
| Issuer: | REGENXBIO INC. (RGNX) |
| Original Submission Date: |
VASISTA VITTAL
C/O REGENXBIO INC.
9600 BLACKWELL ROAD, SUITE 210
ROCKVILLE, MD 20850
| Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
|---|---|---|---|---|---|---|---|---|---|
| COMMON STOCK | 2020-01-08 | M | 3,000 | a | $13.09 | 232,215 | direct | ||
| COMMON STOCK | 2020-01-08 | S | 2,400 | d | $41.40 | 229,815 | direct | ||
| COMMON STOCK | 2020-01-08 | S | 5,100 | d | $41.92 | 224,715 | direct |
| Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMPLOYEE STOCK OPTION (RIGHT TO BUY) | 13.09 | 2020-01-08 | deemed execution date | M | 3,000 (d) | 2026-01-27 | common stock 3,000 | $13.09 | 29,374 | direct |
| ID | footnote |
|---|---|
| f1 | this transaction was effected pursuant to a rule 10b5-1 trading plan. |
| f2 | this transaction was executed in multiple trades at prices ranging from $40.66 to $41.65. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| f3 | this transaction was executed in multiple trades at prices ranging from $41.70 to $42.19. the price reported above reflects the weighted average sale price. the reporting person hereby undertakes to provide upon request to the sec staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| f4 | the previously granted option, representing a right to purchase a total of 75,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on january 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the issuer. |
